Intraocular Lens Market Report 2025

The intraocular lens market size has grown strongly in recent years. It will grow from $5.29 billion in 2024 to $5.78 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to patient expectations and satisfaction, rise in outpatient cataract surgery, introduction of phacoemulsification, evolution of surgical techniques, transition to foldable materials.

The intraocular lens market size is expected to see rapid growth in the next few years. It will grow to $8.72 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to focus on emerging markets, growing aging population, expanding cataract surgery rates, demand for premium IOLs, shift towards outpatient procedures. Major trends in the forecast period include rise in cataract surgeries, shift towards minimally invasive surgery, demand for enhanced visual outcomes, regulatory changes and approvals, evolving surgical techniques.

The intraocular lens market size is expected to see strong growth in the next few years. It will grow to $7.94 billion in 2028 at a compound annual growth rate (CAGR) of 10%. The anticipated growth in the forecast period can be attributed to a focus on emerging markets, the growth of the aging population, an increase in cataract surgery rates, the demand for premium intraocular lenses (IOLs), and a shift towards outpatient procedures. Major trends expected in this period include a rise in cataract surgeries, a shift towards minimally invasive surgery, an increased demand for enhanced visual outcomes, changes in regulations and approvals, and the evolution of surgical techniques.

The rising prevalence of eye diseases is contributing to the growth of the intraocular lens market. Eye diseases such as macular degeneration, glaucoma, and cataracts lead to vision problems. An intraocular lens is an artificial lens related to the eye. It replaces the eye's natural lens that has been removed during cataract surgery. For instance, in October 2022, according to the Association of British Dispensing Opticians, a UK-based professional association for opticians, over two million individuals are in danger of visual loss owing to glaucoma, an estimated 1,390,000 people have ocular hypertension, and another 708,000 have glaucoma. The rising prevalence of eye diseases will drive the intraocular lens market.

The growing geriatric population is expected to drive the expansion of the intraocular lens market in the coming years. This demographic, often referred to as seniors, includes individuals aged 65 and older. Intraocular lenses play a vital role in enhancing vision and improving the overall quality of life for elderly patients, particularly those undergoing cataract surgery. For example, in November 2022, the College of Optometrists, a UK-based professional organization for optometrists, reported that nearly 11 million people in the UK were aged 65 or older in 2022. This number is projected to increase to almost 13 million by 2032, accounting for approximately 22% of the population. Thus, the rise in the geriatric population is significantly influencing the growth of the intraocular lens market.

Technological advancements within the intraocular lens market are becoming increasingly prominent. An illustration of this trend is seen in Alcon's announcement in January 2022, introducing the AcrySof IQ Vivity IOL (Vivity), the inaugural presbyopia-correcting intraocular lens equipped with wavefront-shaping technology. This innovative lens is now accessible to Indian ophthalmologists to offer patients undergoing cataract surgery enhanced visual solutions.

Major companies in the intraocular lens (IOL) market are focusing on developing innovative products, such as small-aperture intraocular lenses, to expand their product portfolios and gain a competitive edge. Small-aperture intraocular lenses are artificial lenses implanted in the eye during cataract surgery or refractive lens exchange procedures. What sets them apart from standard monofocal intraocular lenses is their unique design, which includes a small central aperture. For example, in July 2022, AcuFocus Inc., a US-based medical device company, announced that the FDA had approved its IC-8 Apthera IOL for cataract treatment. The Apthera IOL is the first non-toric extended depth of focus IOL approved for use in 82% of cataract patients with corneal astigmatism of up to 1.5 D. The Apthera IOL stands out for its integrated FilterRing component, which is the first of its kind and helps alleviate presbyopia symptoms by blocking peripheral defocused and aberrated light, thereby enhancing vision quality.

In April 2024, Warburg Pincus LLC, a US-based private equity firm, acquired a stake in Appasamy Associates Pvt Ltd. for an undisclosed amount. This acquisition is part of Warburg Pincus's strategy to expand its presence in the healthcare sector and enhance growth opportunities both domestically and internationally. Appasamy Associates Pvt Ltd. is an India-based medical equipment company specializing in intraocular lenses.

Major companies operating in the intraocular lens market include Abbott Medical Optics Inc., Alcon Inc., Johnson & Johnson Vision Care Inc., Carl Zeiss Meditec AG, Nidek CO. Ltd, Staar Surgical Company, Hoya Corporation, Rayner Intraocular Lenses Limited, SIFI S.p.A, Ophtec, RxSight, Aurolab, Hanita Lenses, Oculentis, Lenstec, EyeKon Medical Inc., Atia Vision, Nayam Innovations, SAV-IOL SA, Biotech Healthcare Group, Physiol, LensGen Inc., Omega Ophthalmics, Ocumetics Technology Corporation, Calhoun Vision Inc., HOYA Surgical Optics, Bausch Health Companies Inc.

Intraocular lens (IOL) is a medical device implanted inside the eye during cataract surgery to replace the natural lens. It is an artificial replacement for the eye's lens and is used for vision correction in refractive lens exchange surgery.

The main types of intraocular lenses (IOLs) include monofocal intraocular lenses, multifocal intraocular lenses, toric intraocular lenses, and accommodating intraocular lenses. Monofocal lenses are the most commonly used in cataract surgery due to their consistent visual outcomes and relative affordability compared to premium alternatives. These lenses are made of materials such as polymethylmethacrylate, silicone, and hydrophobic acrylic. Key end users of intraocular lenses include hospitals, ophthalmic clinics, ambulatory surgery centers, and eye research institutes.

The intraocular lens market size has grown rapidly in recent years. It will grow from $4.93 billion in 2023 to $5.43 billion in 2024 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to patient expectations and satisfaction, rise in outpatient cataract surgery, introduction of phacoemulsification, evolution of surgical techniques, transition from pmma to foldable materials.

North America was the largest region in the intraocular lens market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intraocular lens market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intraocular lens market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The intraocular lens market consists of sales of monofocal intraocular lenses, multifocal intraocular lenses, toric intraocular lenses, and accommodative intraocular lenses that are used for replacing natural lens. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.